Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.94
-0.60 (-7.03%)
At close: Mar 20, 2026, 4:00 PM EDT
8.12
+0.18 (2.27%)
After-hours: Mar 20, 2026, 7:45 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $347.74 million as of March 20, 2026. Its market cap has increased by 209.80% in one year.
Market Cap
347.74M
Enterprise Value
181.63M
1-Year Change
209.80%
Ranking
Category
Stock Price
$7.94
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $347.74M, a decrease of -61.28%. That is a compound annual growth rate of -36.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 453.61M | -15.53% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 389.22M |
| Lineage Cell Therapeutics | 386.09M |
| YD Bio | 381.13M |
| Autolus Therapeutics | 380.58M |
| Niagen Bioscience | 379.58M |
| X4 Pharmaceuticals | 379.14M |
| Enanta Pharmaceuticals | 377.25M |
| DiaMedica Therapeutics | 365.58M |